Recent Advances in Injectable Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 5
Special Issue Editor
Interests: drug formulation and delivery; long-acting injectables; physical pharmacy; lipid-based formulations; cyclodextrins
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue on injectable formulations—one of the most important types of formulation for a variety of biological modalities. This formulation approach contains options for delivery designs that ease the life of patients, e.g., long-acting injectables for systemic or local treatment administered intramuscularly or intravitreally. Innovations such as nanotechnology, biodegradable polymers, and bioresponsive delivery systems are paving the way in personalized medicine, enabling tailored treatments. This Special Issue highlights recent advances in the field of injectable formulations defined in a broad context.
This Special Issue aims to present some of the recent research within the field of injectable formulations, such as research on the formulation, formulation-driven pharmacokinetics, and manufacturing methods.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following: formulation development of injectable formulations, pharmacokinetic investigations, and manufacturing of injectable formulations
I look forward to receiving your contributions.
Prof. Dr. René Holm
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- parenteral
- sterile
- injectable
- lyophillized
- intravenous
- intramuscular
- subcutaneous
- long-acting injectables
- biologicals
- pharmacokinetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
